• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对137个意大利遗传性出血性毛细血管扩张症(HHT)家族的ENG和ACVRL1基因进行分析,发现了76种不同的突变(24种为新突变)。与其他欧洲研究的比较。

Analysis of ENG and ACVRL1 genes in 137 HHT Italian families identifies 76 different mutations (24 novel). Comparison with other European studies.

作者信息

Olivieri Carla, Pagella Fabio, Semino Lucia, Lanzarini Luca, Valacca Cristina, Pilotto Andrea, Corno Sabrina, Scappaticci Susi, Manfredi Guido, Buscarini Elisabetta, Danesino Cesare

机构信息

Biologia Generale e Genetica Medica, University of Pavia, Via Forlanini, 14, 27100, Pavia, Italy.

Clinica Otorinolaringoiatrica, Fondazione IRCCS Policlinico "S. Matteo", Pavia, Italy.

出版信息

J Hum Genet. 2007;52(10):820-829. doi: 10.1007/s10038-007-0187-5. Epub 2007 Sep 5.

DOI:10.1007/s10038-007-0187-5
PMID:17786384
Abstract

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder causing vascular dysplasias. About 70-80% of HHT patients carries mutations in ENG or ACVRL1 genes, which code for a TGFbeta receptor type III and I respectively. Molecular data on a large cohort of Italian HHT patients are presented, discussing the significance of missense and splice site mutations. Mutation analysis in ENG and ACVRL1 genes was performed using single strand conformation polymorphisms (SSCP), denaturing high performance liquid chromatography (DHPLC) and subsequent direct sequencing. Overall, 101 mutations were found, with ACVRL1 involved in 71% of cases. The highest number of mutations (28/101 subjects, 14/76 different mutations referring to both genes) was in ACVRL1, exon 3. Mutation analysis was then extended to a total of 356 family members, and 162 proven to carry the mutation. New polymorphisms were identified in both genes, and evidence that ENG P131L change is not a disease-causing mutation was also provided. An in silico analysis was performed in order to characterize splice-site mutations. These results were compared to other European national studies and data from Italy, France and Spain were consistent for an higher incidence of ACVRL1 mutations.

摘要

遗传性出血性毛细血管扩张症(HHT)是一种导致血管发育异常的常染色体显性疾病。约70-80%的HHT患者携带ENG或ACVRL1基因突变,这两个基因分别编码III型和I型转化生长因子β受体。本文展示了一大组意大利HHT患者的分子数据,讨论了错义突变和剪接位点突变的意义。使用单链构象多态性(SSCP)、变性高效液相色谱(DHPLC)及随后的直接测序对ENG和ACVRL1基因进行突变分析。总体而言,共发现101个突变,其中71%的病例涉及ACVRL1基因。突变数量最多的是ACVRL1基因的第3外显子(28/101例受试者,76个不同突变中有14个涉及这两个基因)。随后对总共356名家庭成员进行了突变分析,其中162人被证实携带该突变。在两个基因中均鉴定出了新的多态性,同时也提供了证据表明ENG基因的P131L改变并非致病突变。进行了计算机分析以表征剪接位点突变。将这些结果与其他欧洲国家的研究进行比较,来自意大利、法国和西班牙的数据一致表明ACVRL1基因突变的发生率较高。

相似文献

1
Analysis of ENG and ACVRL1 genes in 137 HHT Italian families identifies 76 different mutations (24 novel). Comparison with other European studies.对137个意大利遗传性出血性毛细血管扩张症(HHT)家族的ENG和ACVRL1基因进行分析,发现了76种不同的突变(24种为新突变)。与其他欧洲研究的比较。
J Hum Genet. 2007;52(10):820-829. doi: 10.1007/s10038-007-0187-5. Epub 2007 Sep 5.
2
Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients.法国遗传性出血性毛细血管扩张症(HHT)患者中ENG和ACVRL1(ALK1)突变的分布情况。
Hum Mutat. 2006 Jun;27(6):598. doi: 10.1002/humu.9421.
3
Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.挪威遗传性出血性毛细血管扩张症家族的突变分析:ACVRL1中的奠基者突变
Clin Genet. 2016 Feb;89(2):182-6. doi: 10.1111/cge.12612. Epub 2015 Jun 5.
4
The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.ACVRL1基因c.314-35A>G多态性与伴有ENG突变的遗传性出血性毛细血管扩张症患者的器官血管畸形相关,但与伴有ACVRL1突变的患者无关。
Am J Med Genet A. 2015 Jun;167(6):1262-7. doi: 10.1002/ajmg.a.36936. Epub 2015 Apr 2.
5
Mutation analysis of "Endoglin" and "Activin receptor-like kinase" genes in German patients with hereditary hemorrhagic telangiectasia and the value of rapid genotyping using an allele-specific PCR-technique.德国遗传性出血性毛细血管扩张症患者中“内皮糖蛋白”和“激活素受体样激酶”基因的突变分析以及等位基因特异性PCR技术在快速基因分型中的价值。
BMC Med Genet. 2009 Jun 9;10:53. doi: 10.1186/1471-2350-10-53.
6
Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia.韩国遗传性出血性毛细血管扩张症患者ENG、ACVRL1和SMAD4基因的临床特征及突变情况
J Korean Med Sci. 2009 Feb;24(1):69-76. doi: 10.3346/jkms.2009.24.1.69. Epub 2009 Feb 28.
7
High frequency of ENG and ALK1/ACVRL1 mutations in German HHT patients.德国遗传性出血性毛细血管扩张症(HHT)患者中ENG和ALK1/ACVRL1突变的高频率。
Hum Mutat. 2005 Jun;25(6):595. doi: 10.1002/humu.9345.
8
Novel mutations in the ENG and ACVRL1 genes causing hereditary hemorrhagic teleangiectasia.ENG和ACVRL1基因的新型突变导致遗传性出血性毛细血管扩张症。
Int J Mol Med. 2006 Apr;17(4):655-9.
9
Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia.在德国遗传性出血性毛细血管扩张症患者中检测ACVRL1基因突变与肝脏受累之间的显著关联。
Clin Genet. 2008 Aug;74(2):171-7. doi: 10.1111/j.1399-0004.2008.01029.x. Epub 2008 May 21.
10
Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations.遗传性出血性毛细血管扩张症:突变检测、检测敏感性及新突变
J Med Genet. 2006 Sep;43(9):722-8. doi: 10.1136/jmg.2006.042606. Epub 2006 May 11.

引用本文的文献

1
Stereotactic radiosurgery for brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.立体定向放射外科治疗遗传性出血性毛细血管扩张症患者的脑动静脉畸形。
Acta Neurochir (Wien). 2024 Jan 17;166(1):21. doi: 10.1007/s00701-024-05923-4.
2
Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction.遗传性出血性毛细血管扩张症的致病变异频率支持预防心肌梗死的临床证据。
J Clin Med. 2023 Dec 31;13(1):250. doi: 10.3390/jcm13010250.
3
uAUG creating variants in the 5'UTR of ENG causing Hereditary Hemorrhagic Telangiectasia.

本文引用的文献

1
Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network.遗传性出血性毛细血管扩张症的基因型-表型相关性:来自法意遗传性出血性毛细血管扩张症网络的数据。
Genet Med. 2007 Jan;9(1):14-22. doi: 10.1097/gim.0b013e31802d8373.
2
Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.鉴定骨形态发生蛋白9(BMP9)和骨形态发生蛋白10(BMP10)为内皮细胞中孤儿激活素受体样激酶1(ALK1)的功能性激活剂。
Blood. 2007 Mar 1;109(5):1953-61. doi: 10.1182/blood-2006-07-034124. Epub 2006 Oct 26.
3
A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7.
uAUG在ENG基因5'非翻译区产生变异,导致遗传性出血性毛细血管扩张症。
NPJ Genom Med. 2023 Oct 17;8(1):32. doi: 10.1038/s41525-023-00378-5.
4
Silicone septal splint for recurrent epistaxis in HHT patients: experience of a national referral centre.硅胶鼻中隔夹板在遗传性出血性毛细血管扩张症患者反复鼻出血中的应用:一家国家级转诊中心的经验。
Acta Otorhinolaryngol Ital. 2023 Apr;43(Suppl. 1):S28-S33. doi: 10.14639/0392-100X-suppl.1-43-2023-03.
5
Computational and Experimental Analyses for Pathogenicity Prediction of Missense Variants in Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症错义变异致病性预测的计算与实验分析
J Clin Med. 2023 Jul 29;12(15):5002. doi: 10.3390/jcm12155002.
6
Impact of SARS-CoV-2 infection in patients with hereditary hemorrhagic telangiectasia: epidemiological and clinical data from the comprehensive Italian retrospective multicenter study.遗传性出血性毛细血管扩张症患者感染 SARS-CoV-2 的影响:来自意大利综合回顾性多中心研究的流行病学和临床数据。
Intern Emerg Med. 2023 Jun;18(4):1109-1118. doi: 10.1007/s11739-023-03287-8. Epub 2023 May 4.
7
Hereditary Hemorrhagic Telangiectasia: Genetics, Pathophysiology, Diagnosis, and Management.遗传性出血性毛细血管扩张症:遗传学、病理生理学、诊断与管理
J Clin Med. 2022 Sep 5;11(17):5245. doi: 10.3390/jcm11175245.
8
Hereditary hemorrhagic telangiectasia: First demonstration of a founder effect in Italy; the ACVRL1 c.289_294del variant originated in the country of Bergamo 200 years ago.遗传性出血性毛细血管扩张症:意大利首例奠基者效应的证明;ACVRL1 c.289_294del 变异源于 200 年前的贝加莫地区。
Mol Genet Genomic Med. 2022 Aug;10(8):e1972. doi: 10.1002/mgg3.1972. Epub 2022 May 27.
9
BMPR2 mutations and response to inhaled or parenteral prostanoids: a case series.骨形态发生蛋白受体2(BMPR2)突变与吸入或胃肠外前列腺素类药物的反应:病例系列
Pulm Circ. 2021 Dec 6;11(4):20458940211037275. doi: 10.1177/20458940211037275. eCollection 2021 Oct-Dec.
10
Expanding the Evidence of a Semi-Dominant Inheritance in Associated with Pulmonary Arterial Hypertension.扩展与肺动脉高压相关的半显性遗传证据。
Cells. 2021 Nov 15;10(11):3178. doi: 10.3390/cells10113178.
遗传性出血性毛细血管扩张症的第四个基因座定位于7号染色体。
Am J Med Genet A. 2006 Oct 15;140(20):2155-62. doi: 10.1002/ajmg.a.31450.
4
Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype.在对200名接受遗传性出血性毛细血管扩张症(HHT)临床基因检测的个体进行的研究中,发现ENG和ACVRL1基因的新突变:基因型与表型的相关性。
Hum Mutat. 2006 Jul;27(7):667-75. doi: 10.1002/humu.20342.
5
Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients.法国遗传性出血性毛细血管扩张症(HHT)患者中ENG和ACVRL1(ALK1)突变的分布情况。
Hum Mutat. 2006 Jun;27(6):598. doi: 10.1002/humu.9421.
6
Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations.遗传性出血性毛细血管扩张症:突变检测、检测敏感性及新突变
J Med Genet. 2006 Sep;43(9):722-8. doi: 10.1136/jmg.2006.042606. Epub 2006 May 11.
7
SMAD4 mutations found in unselected HHT patients.在未经选择的遗传性出血性毛细血管扩张症(HHT)患者中发现SMAD4突变。
J Med Genet. 2006 Oct;43(10):793-7. doi: 10.1136/jmg.2006.041517. Epub 2006 Apr 13.
8
Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations.德国遗传性出血性毛细血管扩张症的突变分析揭示了11种新的ENG突变和12种新的ACVRL1/ALK1突变。
Clin Genet. 2006 Mar;69(3):239-45. doi: 10.1111/j.1399-0004.2006.00574.x.
9
Echocardiographic screening discloses increased values of pulmonary artery systolic pressure in 9 of 68 unselected patients affected with hereditary hemorrhagic telangiectasia.超声心动图筛查显示,在68例未经挑选的遗传性出血性毛细血管扩张症患者中,有9例肺动脉收缩压值升高。
Genet Med. 2006 Mar;8(3):183-90. doi: 10.1097/01.gim.0000204463.77319.1c.
10
Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations.遗传性出血性毛细血管扩张症的基因型-表型相关性:突变与表现
Am J Med Genet A. 2006 Mar 1;140(5):463-70. doi: 10.1002/ajmg.a.31101.